100 years of Lewy pathology

[1]  E. Katunina,et al.  [Epidemiology of Parkinson's disease]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[2]  Thomas C. Südhof,et al.  Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities , 2012, The Journal of Neuroscience.

[3]  C. Adler,et al.  Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss , 2012, Acta Neuropathologica.

[4]  E. Morignat,et al.  Prion-like acceleration of a synucleinopathy in a transgenic mouse model , 2012, Neurobiology of Aging.

[5]  H. Braak,et al.  Spinal cord lesions in sporadic Parkinson’s disease , 2012, Acta Neuropathologica.

[6]  S. Prusiner,et al.  A Unifying Role for Prions in Neurodegenerative Diseases , 2012, Science.

[7]  O. Levy,et al.  The neuropathology of genetic Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[8]  G. Halliday,et al.  Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease? , 2012, Expert review of neurotherapeutics.

[9]  Christopher M. Dobson,et al.  Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein , 2012, Cell.

[10]  J. Trojanowski,et al.  Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice , 2012, The Journal of experimental medicine.

[11]  K. Shannon,et al.  Is alpha‐synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases , 2012, Movement disorders : official journal of the Movement Disorder Society.

[12]  Miratul M. K. Muqit,et al.  PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65 , 2012, Open Biology.

[13]  H. Braak,et al.  Lewy pathology and neurodegeneration in premotor Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[14]  M. Neunlist,et al.  A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease , 2012, Neurobiology of Disease.

[15]  T. Uchihara,et al.  Pale Neurites, Premature α‐Synuclein Aggregates with Centripetal Extension from Axon Collaterals , 2012, Brain pathology.

[16]  D. Dickson,et al.  Relationship of neighboring tissue and gliosis to α-synuclein pathology in a fetal transplant for Parkinson's disease. , 2012, American journal of neurodegenerative disease.

[17]  S. Kügler,et al.  Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons , 2011, Acta Neuropathologica.

[18]  Tapan P. Patel,et al.  Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.

[19]  W. Westbroek,et al.  Exploring the link between glucocerebrosidase mutations and parkinsonism. , 2011, Trends in molecular medicine.

[20]  J. Kordower,et al.  Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat , 2011, Neurobiology of Disease.

[21]  Patrick A. Lewis,et al.  Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus , 2011, Nature communications.

[22]  E. Waxman,et al.  E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment* , 2011, The Journal of Biological Chemistry.

[23]  B. Lask,et al.  Implications for Treatment , 2011 .

[24]  J. Trojanowski,et al.  α-Syn Suppression Reverses Synaptic and Memory Defects in a Mouse Model of Dementia with Lewy Bodies , 2011, The Journal of Neuroscience.

[25]  Susan Lindquist,et al.  Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations , 2011, Cell.

[26]  E. Masliah,et al.  Enhanced Phosphatase Activity Attenuates α-Synucleinopathy in a Mouse Model , 2011, The Journal of Neuroscience.

[27]  E. Masliah,et al.  Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease , 2011, PloS one.

[28]  G. Halliday,et al.  Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study) , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[29]  P. Brundin,et al.  α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. , 2011, The Journal of clinical investigation.

[30]  J. Bronstein,et al.  The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry. , 2011, Blood cells, molecules & diseases.

[31]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[32]  J. Stockman.  Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease , 2011 .

[33]  A. Petrie,et al.  Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease. , 2011, Journal of Parkinson's disease.

[34]  Yusuke Nakamura,et al.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.

[35]  S. Chandra,et al.  αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction , 2010, Proceedings of the National Academy of Sciences.

[36]  K. Kosaka,et al.  The first autopsied case of diffuse Lewy body disease (DLBD): re‐examination by recent immunostaining methods , 2010, Neuropathology : official journal of the Japanese Society of Neuropathology.

[37]  W. Oertel,et al.  Who was the man who discovered the “Lewy bodies”? , 2010, Movement disorders : official journal of the Movement Disorder Society.

[38]  E. Sidransky,et al.  Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders , 2010, Acta Neuropathologica.

[39]  D. Dickson,et al.  Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies , 2010, Acta Neuropathologica.

[40]  J. Henderson,et al.  α-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra , 2010, PloS one.

[41]  Markus Tolnay,et al.  The propagation of prion-like protein inclusions in neurodegenerative diseases , 2010, Trends in Neurosciences.

[42]  B. Ghetti,et al.  SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. , 2010, Brain : a journal of neurology.

[43]  A. Björklund,et al.  Characterization of Lewy body pathology in 12‐ and 16‐year‐old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[44]  E. Tolosa,et al.  Molecular and clinical prodrome of Parkinson disease: implications for treatment , 2010, Nature Reviews Neurology.

[45]  A. Goris,et al.  Association of the human leucocyte antigen region with susceptibility to Parkinson's disease , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[46]  P. Pástor,et al.  PINK1-linked parkinsonism is associated with Lewy body pathology. , 2010, Brain : a journal of neurology.

[47]  H. Braak,et al.  Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease , 2010, Acta Neuropathologica.

[48]  H. Braak,et al.  A timeline for Parkinson's disease. , 2010, Parkinsonism & related disorders.

[49]  A. Bonnet,et al.  A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death , 2010, Neurobiology of Aging.

[50]  H. Reichmann,et al.  Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice , 2010, PloS one.

[51]  H. Reichmann,et al.  Olfactory Function in Parkinson's Disease , 2010 .

[52]  D. Dickson,et al.  Evidence in favor of Braak staging of Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[53]  R. Youle,et al.  Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.

[54]  D. Dickson,et al.  Neuropathology of non-motor features of Parkinson disease. , 2009, Parkinsonism & related disorders.

[55]  Thomas Gasser,et al.  Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria , 2009, The Lancet Neurology.

[56]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[57]  H. Braak,et al.  Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson’s disease: an anatomical study , 2009, Acta Neuropathologica.

[58]  Nicholas W. Wood,et al.  Genetic Variants of the α-Synuclein Gene SNCA Are Associated with Multiple System Atrophy , 2009, PloS one.

[59]  Brian Spencer,et al.  Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein , 2009, Proceedings of the National Academy of Sciences.

[60]  Sonja W. Scholz,et al.  SNCA variants are associated with increased risk for multiple system atrophy , 2009, Annals of neurology.

[61]  H. Shill,et al.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction , 2009, Acta Neuropathologica.

[62]  A. Lang,et al.  Overview of the extranigral aspects of Parkinson disease. , 2009, Archives of neurology.

[63]  H. Braak,et al.  Neuroanatomy and pathology of sporadic Parkinson's disease. , 2008, Advances in anatomy, embryology, and cell biology.

[64]  V. Pinskerova,et al.  AN ANATOMICAL STUDY , 2009 .

[65]  T. Iwatsubo,et al.  A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans. , 2008, Human molecular genetics.

[66]  Henning Stahlberg,et al.  The fold of α-synuclein fibrils , 2008, Proceedings of the National Academy of Sciences.

[67]  R. Hauser,et al.  Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.

[68]  Elisabet Englund,et al.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.

[69]  D. Dickson,et al.  Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease , 2008, Acta Neuropathologica.

[70]  J. Gore.  The Idea of a National Museum for Australia , 2008 .

[71]  C. Adler,et al.  Reduced striatal tyrosine hydroxylase in incidental Lewy body disease , 2008, Acta Neuropathologica.

[72]  T. Iwatsubo,et al.  Analysis of the Adrenal Gland Is Useful for Evaluating Pathology of the Peripheral Autonomic Nervous System in Lewy Body Disease , 2007, Journal of neuropathology and experimental neurology.

[73]  M. Feany,et al.  Aggregated α-Synuclein Mediates Dopaminergic Neurotoxicity In Vivo , 2007, The Journal of Neuroscience.

[74]  H. Braak,et al.  Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons , 2007, Acta Neuropathologica.

[75]  J. Trojanowski,et al.  Lewy body pathology in Alzheimer’s disease , 2001, Journal of Molecular Neuroscience.

[76]  H. Braak,et al.  Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered , 2006, Movement disorders : official journal of the Movement Disorder Society.

[77]  R. Barbour,et al.  Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease* , 2006, Journal of Biological Chemistry.

[78]  G. Perry,et al.  Emerging evidence for the neuroprotective role of α-synuclein , 2006, Experimental Neurology.

[79]  Dennis W. Dickson,et al.  Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of &agr;-Synucleinopathy , 2006, Journal of neuropathology and experimental neurology.

[80]  Sunhong Kim,et al.  Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin , 2006, Nature.

[81]  Changan Jiang,et al.  Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin , 2006, Nature.

[82]  A. Probst,et al.  α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects , 2006, Neuropathology and applied neurobiology.

[83]  M. Onofrj,et al.  Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium , 2006, Neurology.

[84]  T. Iwatsubo,et al.  Small Molecule Inhibitors of α-Synuclein Filament Assembly† , 2006 .

[85]  Bernardino Ghetti,et al.  Pathological Changes in Dopaminergic Nerve Cells of the Substantia Nigra and Olfactory Bulb in Mice Transgenic for Truncated Human α-Synuclein(1–120): Implications for Lewy Body Disorders , 2006, The Journal of Neuroscience.

[86]  B. Boeve,et al.  α-Synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals , 2006, Neurology.

[87]  J. Langston,et al.  The parkinson's complex: Parkinsonism is just the tip of the iceberg , 2006, Annals of neurology.

[88]  H. Braak,et al.  Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.

[89]  C. Shults.  Lewy bodies. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[90]  Irene Litvan,et al.  Lrrk2 and Lewy body disease , 2006, Annals of neurology.

[91]  H. Braak,et al.  Pathology associated with sporadic Parkinson's disease--where does it end? , 2006, Journal of neural transmission. Supplementum.

[92]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[93]  Makoto Hashimoto,et al.  Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease , 2005, Neuron.

[94]  Satoshi Orimo,et al.  Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease , 2005, Acta Neuropathologica.

[95]  F. Lewy.  Die Entstehung der Einschlußkörper und ihre Bedeutung für die systematische Einordnung der sogenannten Viruskrankheiten , 1932, Deutsche Zeitschrift für Nervenheilkunde.

[96]  U Inserm,et al.  Causal relation between α synuclein gene duplication and familial Parkinson’s disease , 2005 .

[97]  H. Ehringer,et al.  Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems , 2005, Klinische Wochenschrift.

[98]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[99]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[100]  A Dürr,et al.  Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[101]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[102]  Lewy Body‐Related α‐Synucleinopathy in Aging , 2004 .

[103]  Mark A. Wilson,et al.  The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[104]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[105]  J. Obeso,et al.  Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough , 2004, The Lancet Neurology.

[106]  A. Davies,et al.  Parkinson's disease α-synuclein mutations exhibit defective axonal transport in cultured neurons , 2004, Journal of Cell Science.

[107]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[108]  K. Kosaka,et al.  Presenile dementia with Alzheimer-, Pick- and Lewy-body changes , 1976, Acta Neuropathologica.

[109]  Kurt Jellinger,et al.  Amygdala pathology in Parkinson's disease , 2004, Acta Neuropathologica.

[110]  Hitoshi Takahashi,et al.  Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system , 2004, Acta Neuropathologica.

[111]  E. Kuusisto,et al.  Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α‐Synuclein, Ubiquitin, and p62 , 2003, Journal of neuropathology and experimental neurology.

[112]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[113]  R. Blakely,et al.  Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human α‐synuclein , 2003, Journal of neurochemistry.

[114]  Chris Zarow,et al.  Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. , 2003, Archives of neurology.

[115]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[116]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[117]  D. Dickson,et al.  Alpha-synuclein studies are negative in postencephalic parkinsonism of von Economo. , 2002, Neurology.

[118]  P. Aebischer,et al.  α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[119]  J. Trojanowski,et al.  Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein , 2002, Neuron.

[120]  A. Björklund,et al.  Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of α-Synuclein in the Nigrostriatal System , 2002, The Journal of Neuroscience.

[121]  B. Holdorff.  Friedrich Heinrich Lewy (1885–1950) and His Work , 2002, Journal of the history of the neurosciences.

[122]  E. Masliah,et al.  α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.

[123]  John Q. Trojanowski,et al.  Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.

[124]  C. Specht,et al.  Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice , 2001, BMC Neuroscience.

[125]  Michel Goedert,et al.  Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.

[126]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[127]  L. Serpell,et al.  Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[128]  W. Bender,et al.  A Drosophila model of Parkinson's disease , 2000, Nature.

[129]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[130]  Heidi Phillips,et al.  Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.

[131]  R. Krüger,et al.  Increased susceptibility to sporadic Parkinson's disease by a certain combined α‐synuclein/apolipoprotein E genotype , 1999, Annals of neurology.

[132]  K. Iwanaga,et al.  Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases , 1999, Neurology.

[133]  J Q Trojanowski,et al.  Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein , 1998, Annals of neurology.

[134]  Nigel J. Cairns,et al.  Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.

[135]  Hitoshi Takahashi,et al.  α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy , 1998, Neuroscience Letters.

[136]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[137]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[138]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[139]  O. Hornykiewicz,et al.  Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. , 1960, Parkinsonism & related disorders.

[140]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.

[141]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[142]  R. Daroff,et al.  What's in a name? Dr. Lewey and the Lewy body , 1997, Neurology.

[143]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[144]  K. Wakabayashi,et al.  Neuropathology of autonomic nervous system in Parkinson's disease. , 1997, European neurology.

[145]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[146]  Nir Giladi,et al.  Occurrence of Parkinson's syndrome in type I Gaucher disease. , 1996, QJM : monthly journal of the Association of Physicians.

[147]  K. Jellinger,et al.  Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. , 1991, Molecular and chemical neuropathology.

[148]  Peter L. Lantos,et al.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) , 1989, Journal of the Neurological Sciences.

[149]  A. Benabid,et al.  Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. , 1987, Applied neurophysiology.

[150]  M W Mahowald,et al.  Chronic behavioral disorders of human REM sleep: a new category of parasomnia. , 1986, Sleep.

[151]  W. Travis,et al.  A Report of Three Cases , 1986 .

[152]  S. Qualman,et al.  Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. , 1984, Gastroenterology.

[153]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[154]  A. Johnson,et al.  Olfactory function in patients with Parkinson's disease. , 1975, Journal of chronic diseases.

[155]  R. Mulcahy,et al.  PRIMARY PREVENTION , 1975, The Lancet.

[156]  N. Krasner,et al.  L-dopa for postencephalitic Parkinsonism. , 1970, British medical journal.

[157]  L. Schiffer,et al.  Aromatic amino acids and modification of parkinsonism. , 1967, The New England journal of medicine.

[158]  V. Tennyson,et al.  Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra and Locus Caeruleus in Parkinson's Disease , 1965 .

[159]  J. Bogdanowicz,et al.  REPORT OF THREE CASES. , 1963, American journal of diseases of children.

[160]  O. Hornykiewicz,et al.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia]. , 1961, Wiener klinische Wochenschrift.

[161]  S. Aronson,et al.  AN ANATOMICAL STUDY , 1961 .

[162]  W. J. German.  The Diseases of the Basal Ganglia , 1943, The Yale Journal of Biology and Medicine.

[163]  O. Bumke,et al.  Handbuch der Neurologie , 1936 .

[164]  S. Bradbury,et al.  Postural hypotension: A report of three cases , 1925 .

[165]  F. Lewy.  Die Lehre vom Tonus und der Bewegung : Zugleich systematische Untersuchungen zur Klinik, Physiologie, Pathologie und Pathogenese der paralysis Agitans , 1923 .

[166]  F. Lewy.  Paralysis agitans. I. Pathologische Anatomie , 1912 .

[167]  Gonzalo R. Lafora,et al.  Beitrag zur Histopathologie der myoklonischen Epilepsie , 1911 .

[168]  J. Charcot,et al.  Lecons Sur Les Maladies Du Systeme Nerveux , 1902, The Indian Medical Gazette.

[169]  P. Blocq,et al.  Sur un cas de tremblement parkinsonien hémiplégique symptomatique d'une tumeur du pédoncule cérébral , 1893 .

[170]  J. Parkinson.  An Essay on the Shaking Palsy , 2002 .